{"id":"W189243586","doi":"10.1016/j.jacc.2012.11.082","title":"N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation","year":2013,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Hazard ratio; Apixaban; Atrial fibrillation; Internal medicine; Natriuretic peptide; Quartile; Cardiology; Stroke (engine); Confidence interval; Proportional hazards model; Heart failure; Warfarin; Rivaroxaban","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003799666,0.0001010569,0.0007040489,0.0001760918,0.0000386803,0.000004735429,0.0001006021,0.00003431679,0.000009043035],"category_scores_gemma":[0.0003915777,0.00005798488,0.0003596234,0.0003173977,0.000136869,0.00008500618,0.00003507822,0.0001396039,0.000001012749],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001008785,"about_ca_system_score_gemma":0.000184648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001151728,"about_ca_topic_score_gemma":0.000001856549,"domain_scores_codex":[0.9987786,0.0001899777,0.000511495,0.0000950558,0.0002826726,0.0001422214],"domain_scores_gemma":[0.9978479,0.0002855098,0.001143148,0.0001605455,0.0005185776,0.00004430559],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002489174,0.000002249776,0.9918001,0.00001922586,0.0002677067,0.000004434236,0.00001034991,0.002577822,0.00004034954,0.00004902421,0.001170513,0.001568992],"study_design_scores_gemma":[0.004148588,0.002972104,0.9874803,0.00003818363,0.000371483,0.00003874723,0.0001038115,0.0002446755,0.00001157338,0.0002090451,0.004317614,0.00006384196],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960712,0.00003397684,0.0003621834,0.001967733,0.0003611411,0.001012021,0.00001335836,0.000003092599,0.0001752684],"genre_scores_gemma":[0.9950567,0.00003103478,0.003551991,0.00003719206,0.0011544,7.879891e-7,0.000002589699,0.00001142064,0.000153834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004319827,"threshold_uncertainty_score":0.2364555,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0183666870065646,"score_gpt":0.3061694345619166,"score_spread":0.287802747555352,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}